Skip to main content

Navigation group

Type at least 3 characters
1,811 articles

Articles

Original Research

Published on 19 May 2023

Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

in Molecular Diagnostics and Therapeutics

  • Maria Carmen Rodenas
  • Julia Peñas-Martínez
  • Irene Pardo-Sánchez
  • David Zaragoza-Huesca
  • Carmen Ortega-Sabater
  • Jorge Peña-García
  • Salvador Espín
  • Guillermo Ricote
  • Sofía Montenegro
  • Francisco Ayala-De La Peña
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2023.1182925
  • 4,490 views
  • 1 citation